IL6 and delirium: To our knowledge, this is the first study to identify the high IL6 levels in the serum of COVID-19 hospitalised patients with neurological symptoms (delirium) as the molecular mechanism leading to disruption in neurogenic processes, measured in vitro using a unique human model of hippocampal precursors.